These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23049645)

  • 1. Effect of novel synthetic evodiamine analogue on sexual behavior in male rats.
    Vyawahare NS; Hadambar AA; Chothe AS; Jalnapurkar RR; Bhandare AM; Kathiravan MK
    J Chem Biol; 2012 Jan; 5(1):35-42. PubMed ID: 23049645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Evodiamine Derivatives as Highly Selective PDE5 Inhibitors Targeting a Unique Allosteric Pocket.
    Zhang T; Lai Z; Yuan S; Huang YY; Dong G; Sheng C; Ke H; Luo HB
    J Med Chem; 2020 Sep; 63(17):9828-9837. PubMed ID: 32794708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil (Viagra) in the treatment of male erectile dysfunction in Nairobi.
    Magoha GA
    East Afr Med J; 2000 Feb; 77(2):76-9. PubMed ID: 10774079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.
    Cui Y; Liu X; Shi L; Gao Z
    Andrologia; 2016 Feb; 48(1):20-8. PubMed ID: 25684196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction.
    Govier F; Potempa AJ; Kaufman J; Denne J; Kovalenko P; Ahuja S
    Clin Ther; 2003 Nov; 25(11):2709-23. PubMed ID: 14693299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction: Pharmacology and Clinical Impact of the Sildenafil Citrate Orodispersible Tablet Formulation.
    Scaglione F; Donde S; Hassan TA; Jannini EA
    Clin Ther; 2017 Feb; 39(2):370-377. PubMed ID: 28139291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G; Nelli F; Celso M; Mencarini M; Del Popolo G
    J Sex Med; 2012 Apr; 9(4):970-85. PubMed ID: 22304626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study.
    Huang YY; Li Z; Cai YH; Feng LJ; Wu Y; Li X; Luo HB
    J Chem Inf Model; 2013 Nov; 53(11):3044-53. PubMed ID: 24180640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and tolerance of PDE-5 in the treatment of erectile dysfunction in schizophrenic patients: A literature review].
    Bacconi L; Gressier F
    Encephale; 2017 Feb; 43(1):55-61. PubMed ID: 27658991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for managing sexual dysfunction induced by antidepressant medication.
    Taylor MJ; Rudkin L; Bullemor-Day P; Lubin J; Chukwujekwu C; Hawton K
    Cochrane Database Syst Rev; 2013 May; (5):CD003382. PubMed ID: 23728643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Balhara YP; Sarkar S; Gupta R
    Indian J Endocrinol Metab; 2015; 19(4):451-61. PubMed ID: 26180759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives.
    Costa P; Grivel T; Gehchan N
    Patient Prefer Adherence; 2009 Nov; 3():105-11. PubMed ID: 19936152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference.
    Ströberg P; Murphy A; Costigan T
    Clin Ther; 2003 Nov; 25(11):2724-37. PubMed ID: 14693300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors.
    Campbell N; Clark JP; Stecher VJ; Thomas JW; Callanan AC; Donnelly BF; Goldstein I; Kaminetsky JC
    J Sex Med; 2013 Jul; 10(7):1842-9. PubMed ID: 23634714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of PDE5 inhibitors.
    Rashid A
    Clin Cornerstone; 2005; 7(1):47-56. PubMed ID: 16156423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
    Conti CR; Pepine CJ; Sweeney M
    Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.